Arterial and venous thrombotic complications with thalidomide in multiple myeloma.
Alkindi
Salam
S
Dennison
David
D
Pathare
Anil
A
D000284:Administration, Oral; D000368:Aged; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000139:chemically induced*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors; D020246:Venous Thrombosis / Q000139:chemically induced*
D007166:Immunosuppressive Agents; D013792:Thalidomide